These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1057692)

  • 61. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advanced glycation endproducts (AGEs) as uremic toxins.
    Schwenger V; Zeier M; Henle T; Ritz E
    Nahrung; 2001 Jun; 45(3):172-6. PubMed ID: 11455783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Metabolic anomaly and uremic toxins in chronic renal insufficiency].
    Ueda Y
    Nihon Rinsho; 1974 Mar; 32(3):446-8. PubMed ID: 4859022
    [No Abstract]   [Full Text] [Related]  

  • 64. Uremic middle molecules: separation and quantitation.
    Chapman GV; Farrell PC
    Artif Organs; 1981; 4 Suppl():160-5. PubMed ID: 7295084
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Uremia toxins: effect of medium and high molecular fractions from normal urine on gluconeogenesis of the kidney cortex sections in the rat].
    Lamberts B; Brunner H; Heintz R
    Verh Dtsch Ges Inn Med; 1974; 80():722-5. PubMed ID: 4454647
    [No Abstract]   [Full Text] [Related]  

  • 66. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 67. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Harnessing transporters to clear uremic toxins.
    Moe OW
    J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
    [No Abstract]   [Full Text] [Related]  

  • 69. [Uremic toxin and dialysis].
    Nakagawa S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):430-2. PubMed ID: 988349
    [No Abstract]   [Full Text] [Related]  

  • 70. [Aluminium poisoning in uremic children].
    Hinojosa-Lezama M; Gordillo-Paniagua G
    Bol Med Hosp Infant Mex; 1986 Sep; 43(9):532-6. PubMed ID: 3790225
    [No Abstract]   [Full Text] [Related]  

  • 71. What causes toxicity in uraemia?
    Br Med J; 1977 Jul; 2(6080):143-4. PubMed ID: 871815
    [No Abstract]   [Full Text] [Related]  

  • 72. [Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins].
    Wratten ML; Sereni L; Lupotti M; Ghezzi PM; Atti M; Formica M
    G Ital Nefrol; 2004; 21 Suppl 30():S67-70. PubMed ID: 15747308
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uremic toxins.
    Vanholder R
    Adv Nephrol Necker Hosp; 1997; 26():143-63. PubMed ID: 8922131
    [No Abstract]   [Full Text] [Related]  

  • 74. Improved separation and quantification of the "middle molecule" b4-2 in uremia.
    Faguer P; Man NK; Cueille G; Di Giulio S; Funck-Brentano JL
    Clin Chem; 1983 Apr; 29(4):703-7. PubMed ID: 6831703
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjects.
    Mabuchi H; Nakahashi H
    Clin Chem; 1983 Apr; 29(4):675-7. PubMed ID: 6831696
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence that urea is a better surrogate marker of uremic toxicity than creatinine.
    Mehrotra R; Saran R; Nolph KD; Moore HL; Khanna R
    ASAIO J; 1997; 43(5):M858-61. PubMed ID: 9360168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Muscle intracellular electrolytes in patients with chronic uremia.
    Bergström J; Alvestrand A; Fürst P; Hultman E; Widstam-Attorps U
    Kidney Int Suppl; 1983 Dec; 16():S153-60. PubMed ID: 6588246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 79. Do middle molecules cause uremic intoxication? (Con).
    Kjellstrand CM
    Am J Kidney Dis; 1981 Jul; 1(1):51-6. PubMed ID: 7332001
    [TBL] [Abstract][Full Text] [Related]  

  • 80. From uremic toxin retention to removal by convection: do we know enough?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Contrib Nephrol; 2008; 161():125-131. PubMed ID: 18451668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.